Ticagrelor and thrombolysis in myocardial infarction: what does the TREAT study change? by O. V. Averkov, V. I. Vechorko

Get full text

Selection of P2Y12 antagonist in patients with myocardial infarction who received thrombolytic therapy. Results of annual follow-up of TREAT study patients by O. V. Averkov, V. I. Vechorko

Get full text

New SARS-CoV-2 Omicron variant — clinical picture, treatment, prevention (literature review) by V. I. Vechorko, O. V. Averkov, A. A. Zimin

Get full text

LIFE QUALITY IN ONE YEAR AFTER MYOCARDIAL INFRACTION WITH INCOPLETE REVASCULARIZATION by A. S. Semiokhina, E. O. Taratukhin, N. L. Bayandin, I. G. Gordeev, V. I. Vechorko

Get full text

COVID-19 infection after recent heart transplantation: a case report by V. I. Vechorko, I. G. Gordeev, E. V. Gubareva, E. V. Ryndyaeva, O. V. Averkov

Get full text

MALIGNANT HYPERTENSION WITH PREDOMINANT KIDNEY DAMAGE by N. D. Lapochkina, S. S. Mamedguseyinova, L. V. Korsakova, V. I. Vechorko, S. M. Otarova, I. G. Gordeev

Get full text

Factors and mechanisms of arterial hypertension development in patients with atherosclerosis of lower limb arteries by E. M. Evsikov, V. I. Vechorko, N. V. Teplova, M. H. Zhapueva, N. G. Artamonova

Get full text

A Model for Predicting the Risk of Developing Drug-Induced Liver Injury During Therapy with Favipiravir by Yu. V. Shevchuk, I. V. Sychev, A. V. Kryukov, I. I. Temirbulatov, K. B. Mirzaev, N. P. Denisenko, Sh. P. Abdullaev, S. N. Tuchkova, V. I. Vechorko, O. V. Averkov, D. A. Sychev

Get full text

Safety of Pharmacotherapy in COVID-19 Patients: A Literature Review by A. V. Kryukov, A. S. Zhiryakova, Yu. V. Shevchuk, A. V. Matveev, V. I. Vechorko, O. V. Averkov, S. V. Glagolev, I. I. Temirbulatov, K. B. Mirzaev, N. P. Denisenko, Sh. P. Abdullaev, D. A. Sychev

Get full text